PHS issues statement on postexposure zidovudine use.
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D006801:Humans; D009784:Occupational Diseases / Q000517:prevention & control*; D014481:United States; D014492:United States Public Health Service; D015215:Zidovudine / Q000627:therapeutic use*
D015215:Zidovudine